2017
DOI: 10.3348/kjr.2017.18.1.152
|View full text |Cite
|
Sign up to set email alerts
|

Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance

Abstract: ObjectiveTo assess whether contrast-enhanced ultrasonography (CEUS) with Sonazoid can improve the lesion conspicuity and feasibility of percutaneous biopsies for focal hepatic lesions invisible on fusion imaging of real-time ultrasonography (US) with computed tomography/magnetic resonance images, and evaluate its impact on clinical decision making.Materials and MethodsThe Institutional Review Board approved this retrospective study. Between June 2013 and January 2015, 711 US-guided percutaneous biopsies were p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
35
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 30 publications
(35 citation statements)
references
References 30 publications
0
35
0
Order By: Relevance
“…However, one of the main challenges during US-guided biopsy is poor lesion conspicuity on conventional B-mode US [134]. When biopsy targets are not well depicted or not visualized on conventional B-mode US, the use of Sonazoid can be helpful to enhance the visualization of targets [53,135,136]. Lesion detection rates were significantly improved during the vascular phase (84.0%) and postvascular phase (Kupffer phase) (92.3%) in comparison to conventional B-mode US (77.3%) [136].…”
Section: Chapter 4: Guiding Intervention Biopsymentioning
confidence: 99%
See 2 more Smart Citations
“…However, one of the main challenges during US-guided biopsy is poor lesion conspicuity on conventional B-mode US [134]. When biopsy targets are not well depicted or not visualized on conventional B-mode US, the use of Sonazoid can be helpful to enhance the visualization of targets [53,135,136]. Lesion detection rates were significantly improved during the vascular phase (84.0%) and postvascular phase (Kupffer phase) (92.3%) in comparison to conventional B-mode US (77.3%) [136].…”
Section: Chapter 4: Guiding Intervention Biopsymentioning
confidence: 99%
“…One limitation of this study was that the choice of B-mode US and Sonazoid CEUS was based on the operator's decision, and not based on the predetermined criteria. The reported technical success rates on Sonazoid CEUS ranges from 87.6% to 92.3%; these numbers are quite high considering that biopsy cannot be even attempted without the use of Sonazoid [53,135,136].…”
Section: Chapter 4: Guiding Intervention Biopsymentioning
confidence: 99%
See 1 more Smart Citation
“…In total, 50 KJR (9101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354565758), 492 ER, and 254 Radiology articles reported original research studies analyzing patient data. Of these, 44 (88%; 95% CI: 75.8–94.8%) (910121314151617181920212324262728293031323435363738394041424344474849505152535455565758), 359 (73%; 95% CI: 68.9–76.7%), and 211 (83.1%; 95% CI: 78–87.2%) articles, respectively, revealed the start and end of data collection to the level of calendar month.…”
Section: Resultsmentioning
confidence: 99%
“…Of these, 44 (88%; 95% CI: 75.8–94.8%) (910121314151617181920212324262728293031323435363738394041424344474849505152535455565758), 359 (73%; 95% CI: 68.9–76.7%), and 211 (83.1%; 95% CI: 78–87.2%) articles, respectively, revealed the start and end of data collection to the level of calendar month. The point estimate value of this proportion was slightly larger in KJR than in ER and Radiology, although the difference was not statistically significant.…”
Section: Resultsmentioning
confidence: 99%